symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
KTTA,0.4512,0.735136,147932,9393984,0,0.31-1.127,0.0266,Pasithea Therapeutics Corp.,USD,0001841330,US70261F1030,70261F103,NASDAQ Capital Market,NASDAQ,Biotechnology,https://www.pasithea.com,"Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.","Dr. Tiago Reis Marques M.D., Ph.D.",Healthcare,US,15,702 514 4174,1111 Lincoln Road,Miami Beach,FL,33139,,0,https://financialmodelingprep.com/image-stock/KTTA.png,2021-09-15,False,False,True,False,False
